Founder, Chief Executive Officer and President

Chief Financial Officer and Executive Vice President, Corporate Strategy

Unpacking the FDA transparency push on CRLs

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx placed on 'Positive Catalyst Watch' at JPMorgan

Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President

Associate Director, Global Medical Communications

Ultragenyx Pharmaceutical is dedicated to leading the future of rare disease medicine and creating impactful treatments for patients. The Global Medical Communications Lead will develop and execute the medical communications strategy for their rare disease portfolio, ensuring effective communication of data across various stakeholders and channels.

Senior Vice President, Global Brand Strategy

Senior Director, Global Internal Communications

SVP, Global Corporate Communications

Senior Manager, Global Medical Information and Communications

Senior Director, US Marketing

Sign up with Google

Sign in with Google